Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2026-01-02 @ 11:26 AM
Study NCT ID:
NCT00291850
Status:
TERMINATED
Last Update Posted:
2012-05-01
First Post:
2006-02-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC
Sponsor:
Central European Cooperative Oncology Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CECOG/NSCLC.3.2.002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None